This study is multi-center, single arm, open-label, phase 4 study to evaluate the efficacy and safety of CertiroBell® tablet plus tacrolimus in primary living donor liver transplant recipients.
To evaluate the efficacy and safety of CertiroBell® tablet plus tacrolimus